Read more about the article Novo Nordisk Wegovy pill launch makes strong early impact on U.S. market and investor sentiment
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026.
Health

Novo Nordisk Wegovy pill launch makes strong early impact on U.S. market and investor sentiment

Novo Nordisk Wegovy pill launch news dominated market talk as the company’s first-ever GLP-1 oral weight-loss medicine drew notable early U.S. prescription data and lifted shares, marking a promising turnaround…

Comments Off on Novo Nordisk Wegovy pill launch makes strong early impact on U.S. market and investor sentiment
January 18, 2026